Factory Provide High Quality Omeprazole Powder CAS 73590-58-6

Introduction

Product Name : Omeprazole 

Other name:1h-benzimidazole,5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulf;2-Chloromethyl-3,5-dinmethyl-4-methoxypyridine

CAS No.:73590-58-6

MF: C17H19N3O3S

Purity :99%

MW:345.42

Melting Point :156°C

Boiling Point ：600.0±60.0 °C(Predicted)

Appearance: White to off white Powder

Density :1.332 g/cm3

Storage :Sealed in dry,Sealed in dry,Room Temperature

Omeprazole, not Mingluosaike, is a way to effectively inhibit gastric acid secretion proton pump inhibitors. There protease inhibition of gastric secretion of gastric mucosal blood flow change is not obvious, does not affect body temperature, stomach cavity temperature, arterial blood pressure, venous hemoglobin, arterial oxygen, carbon dioxide partial pressure and arterial blood pH. 
Binds covalently to proton pump. It inhibits gastric secretion. Used as an anttiulcerative.

Function:

1. The proper digestion and absorption of protein and fat;
2. To help in the essential amion acid tryptophan is converted to nicotinic acid;
3. To prevent all kinds of nerves, skin diseases;
4. Alleviate vomiting;
5. Promote the nucleic acid Synthesis, to prevent the aging of tissues and organs;
6. Lower the result of taking antidepressants caused by dry mouth and dysuria
7. Slow night muscle spasms, cramps paralysis and other symptoms of hand,foot and neuritis;
8. Is the natural the diuretic.
9. Treatment of congenital hypofunction of metabolism;
10. Prevent and treat vitamin B6 deficiency;
11. Supplement to patients who need to consume more vitamin B6;
12. Treatment of carpal tunnel syndrome

Application:

1. Peptic ulcer bleeding and anastomotic ulcer bleeding;
2. Acute gastric mucosal injury complicated by stress and acute gastric mucosal injury caused by nonsteroidal anti-inflammatory drugs;
3. Prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.) stress state and upper gastrointestinal bleeding caused by gastric surgery;
4. As an alternative when oral therapy is not appropriate for duodenal ulcer, gastric ulcer, reflux esophagitis, and zollinger-ellison syndrome;
5.Applied in pharmaceutical filed, drugs inhibiting gastric acid secretion.